C4 Therapeutics Inc. (CCCC)
NASDAQ: CCCCHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
After hours: 2.83 +0.35%
CCCC stock chart
Technical analysisKey statistics
All statistics- Market cap
- $346.93M
- EPS (TTM)
- -$0.91
- Dividend yield
- None
- 52-week range
- 1.69 – 5.17
- Day range
- 2.82 – 2.95
- Volume / Avg
- 2.27M / 2.45M
- Beta
- —
- Shares outstanding
- 123.03M
- Next earnings
- Nov 5, 2026
52-week range
CCCC stock today
On Oct 7, CCCC ended the session at $2.82, shedding $0.06 (2.08%), versus the S&P 500's 0.22% decline. At this level, CCCC sits in the middle of its 52-week range of $1.69 to $5.17: 45.5% below the high, set on Jun 30, 2026 and 66.9% above the low. CCCC is up 47.6% year to date, outperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has gained 24.8%.
C4 Therapeutics has posted a net loss over the last twelve months (EPS of -$0.91), so its P/E ratio is not meaningful. C4 Therapeutics's next earnings report is expected on Nov 5, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About C4 Therapeutics
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- IPO year
- 2020
Earnings
Earnings history- Next report
- Nov 5, 2026
- EPS estimate
- $-0.21
C4 Therapeutics peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| FENCFennec Pharmaceuticals Inc. | 10.36 | +0.10% | $363.30M | vs CCCC |
| ARTVArtiva Biotherapeutics Inc. | 7.00 | -3.71% | $342.23M | vs CCCC |
| AGENAgenus Inc. | 7.57 | +1.07% | $341.88M | vs CCCC |
| OCGNOcugen Inc. | 1.00 | -3.85% | $339.11M | vs CCCC |
| CABACabaletta Bio Inc. | 1.97 | -2.48% | $334.00M | vs CCCC |
| SCTXScribe Therapeutics Inc. | 17.57 | +7.59% | $332.63M | vs CCCC |
| KYTXKyverna Therapeutics Inc. | 6.17 | +0.16% | $381.57M | vs CCCC |
| ZURAZura Bio Limited Class A | 4.17 | +5.30% | $399.61M | vs CCCC |
Indexes, lists and sector
Largest Health Care stocks
C4 Therapeutics stock FAQ
What is C4 Therapeutics's stock price today?
CCCC last traded at $2.82 as of Oct 7, 4:00 PM EDT, down 2.08% on the day. Prices are delayed at least 15 minutes.
When is C4 Therapeutics's next earnings date?
C4 Therapeutics is expected to report earnings on Thursday, November 5, 2026. Analysts expect EPS of $-0.21.
What is the CCCC 52-week high?
The 52-week high for CCCC is $5.17 and the 52-week low is $1.69. The stock is currently 45.5% below its high.